Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 4 Antibiotic susceptibility profiles of the Gram-positive MDR ESKAPEE bacterial pathogens

From: Environmental contamination across multiple hospital departments with multidrug-resistant bacteria pose an elevated risk of healthcare-associated infections in Kenyan hospitals

Antimicrobial agent

MRSA, n = 5 (%)

E. faecium and E. faecalis, n = 2 (%)

 

NS

S

NS

S

Cefoxitin

5 (100)

0

nd

nd

Penicillin

5 (100)

0

nd

nd

Oxacillin

5 (100)

0

nd

nd

Erythromycin

5 (100)

0

2 (100)

0

Gentamycin

5 (100)

0

nd

nd

Clindamycin

5 (100)

0

nd

nd

Linezolid

0

5/5 (100)

0

2 (100)

Levofloxacin

4 (80)

1/5 (20.0)

2 (100)

0

Moxifloxacin

4 (80)

1/5 (20.0)

ND

nd

Tetracycline

3 (60)

2/5 (40.0)

2 (100)

0

Tigecycline

0

5/5 (100)

0

2 (100)

Nitrofurantoin

0

5/5 (100)

2 (100)

0

Trimethoprim-sulfamethoxazole

5 (100)

0

nd

nd

Teicoplanin

0

5/5 (100)

0

2 (100)

Vancomycin

0

5/5 (100)

0

2 (100)

Fusidic Acid

0

5/5 (100)

nd

nd

  1. Abbreviations: NS, non-susceptible (Resistant or Intermediate); S, Susceptible; nd, antimicrobial sensitivity testing not done; MRSA Methicillin resistant S. aureus